The Diet Solution Program

FDA Advisers Back Weight-Loss Drug Qnexa

WEDNESDAY, Feb. 22 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel gave its blessing Wednesday to a highly anticipated weight loss pill that had been rejected by health advisers once before.

FDA panel OKs previously rejected weight-loss pill Qnexa

SILVER SPRING, Md. (AP) — A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade.

FDA advisors endorse weight-loss drug Qnexa

In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999.

Qnexa: FDA Panel Recommends Approval for Weight-Loss Drug

A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade. The Food and Drug Administration has rejected three weight loss pills in the last two [...]

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel

Vivus Inc.’s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years.

FDA panel backs weight loss drug Qnexa

An experimental obesity drug from Vivus Inc won a U.S. panel's support on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years.

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Advisory Panel

Vivus Inc. (VVUS) ’s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years.

FDA Weighs Fate of Qnexa for Weight Loss, Again

WEDNESDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects.

New Weight-Loss Equation: Researchers Determine Key Calorie Cutoff

VANCOUVER — Weight loss is not as simple as eating less and exercising more, and for those who struggle to shed the pounds, a new equation may offer some help.

Weight loss not so simple as previously thought?

Weight loss is not as simple as eating less and exercising more, and for those who struggle to shed the pounds, a new equation may offer some help

Source: